Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury

Stem Cells

Volumn 31, Issue 2, 2013, Pages 372-383

  Porter, Rebecca L ^a   Georger, Mary A ^b   Bromberg, Olga ^a   Mcgrath, Kathleen E ^c   Frisch, Benjamin J ^b   Becker, Michael W ^a   Calvi, Laura M ^a,b  

^a Department of Medicine ^*  (United States)

^b School of Medicine   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Apoptosis; Bone marrow; Hematopoietic stem cells; Irradiation; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 2; DMPGE2; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RADIATION INJURY; WHOLE BODY RADIATION;

ACTINS; ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR MICROENVIRONMENT; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; MACROPHAGES; MALE; MICE; MICE, TRANSGENIC; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; WHOLE-BODY IRRADIATION;

EID: 84874320587     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1286     Document Type: Article

References (50)

1. Porter RL, Calvi LM. Communications between bone cells and hematopoietic stem cells. Arch Biochem Biophys 2008;473: 193-200.
2. Calvi LM, Adams GB, Weibrecht KW et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003;425: 841-846. (Pubitemid 37351468)
3. Adams GB, Martin RP, Alley IR et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol 2007;25:238-243. (Pubitemid 46227124)
4. Mendez-Ferrer S, Michurina TV, Ferraro F et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010;466:829-834.
5. Bromberg O, Frisch BJ, Weber JM et al. Osteoblastic N-Cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. Blood 2012;120:303-313.
6. Tetradis S, Pilbeam CC, Liu Y et al. Parathyroid hormone increases prostaglandin G/H synthase-2 transcription by a cyclic adenosine 30,50-monophosphate-mediated pathway in murine osteoblastic MC3T3-E1 cells. Endocrinology 1997;138:3594-3600. (Pubitemid 27351904)
7. Tintut Y, Parhami F, Tsingotjidou A et al. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 2002;277:14221-14226. (Pubitemid 34968036)
8. North TE, Goessling W, Walkley CR et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007;447: 1007-1011. (Pubitemid 46975751)
9. Goessling W, North TE, Loewer S et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009;136:1136-1147.
10. Hoggatt J, Singh P, Sampath J et al. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood 2009; 113:5444-5455.
11. Frisch BJ, Porter RL, Gigliotti BJ et al. In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. Blood 2009;114: 4054-4063.
12. Goessling W, Allen RS, Guan X et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 2011;8:445-458.
13. Ippoliti AF, Isenberg JI, Maxwell V et al. The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients. Gastroenterology 1976;70: 488-491.
14. Ippoliti AF, Isenberg JI, Hagie L. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients. Gastroenterology 1981;80:55-59. (Pubitemid 11213288)
15. Frisch BJ, Ashton JM, Xing L et al. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood 2012;119:540-550.
16. Vassiliou E, Sharma V, Jing H et al. Prostaglandin E2 promotes the survival of bone marrow-derived dendritic cells. J Immunol 2004;173: 6955-6964. (Pubitemid 39541084)
17. Neilan TG, Doherty GA, Chen G et al. Disruption of COX-2 modulates gene expression and the cardiac injury response to doxorubicin. Am J Physiol Heart Circ Physiol 2006;291:H532-536. (Pubitemid 44175057)
18. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
19. Sheng H, Shao J, Morrow JD et al. Modulation of apoptosis and Bcl- 2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998;58:362-366. (Pubitemid 28047080)
20. Pelus LM, Hoggatt J, Singh P. Pulse exposure of haematopoietic grafts to prostaglandin E2 in vitro facilitates engraftment and recovery. Cell Prolif 2011;44(suppl 1):22-29.
21. Belkacemi Y, Bouchet S, Frick J et al. Monitoring of residual hematopoiesis after total body irradiation in humans as a model for accidental x-ray exposure: Dose-effect and failure of ex vivo expansion of residual stem cells in view of autografting. Int J Radiat Oncol Biol Phys 2003;57:500-507. (Pubitemid 37040948)
22. Grande T, Varas F, Bueren JA. Residual damage of lymphohematopoietic repopulating cells after irradiation of mice at different stages of development. Exp Hematol 2000;28:87-95. (Pubitemid 30047194)
23. Stewart FM, Zhong S, Lambert JF et al. Host marrow stem cell potential and engraftability at varying times after low-dose whole-body irradiation. Blood 2001;98:1246-1251.
24. Notta F, Doulatov S, Laurenti E et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011;333:218-221.
25. Gentile P, Byer D, Pelus LM. In vivo modulation of murine myelopoiesis following intravenous administration of prostaglandin E2. Blood 1983;62:1100-1107. (Pubitemid 14237334)
26. Bradley TR, Hodgson GS. Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood 1979;54:1446-1450. (Pubitemid 10212787)
27. Ebbe S, Stohlman F, Jr., Donovan J et al. Megakaryocyte maturation rate in thrombocytopenic rats. Blood 1968;32:787-795.
28. Tanum G. The megakaryocyte DNA content and platelet formation after the sublethal whole body irradiation of rats. Blood 1984;63: 917-920. (Pubitemid 14141315)
29. Huang Q, Li F, Liu X et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 2011;17: 860-866.
30. O'Banion MK. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 1999;13:45-82. (Pubitemid 29231727)
31. Fordyce C, Fessenden T, Pickering C et al. DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions. Cancer Prev Res (Phila) 2010;3:190-201.
32. Buckman SY, Gresham A, Hale P et al. COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer. Carcinogenesis 1998;19:723-729. (Pubitemid 28376760)
33. Pilbeam CC, Kawaguchi H, Hakeda Y et al. Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J Biol Chem 1993;268:25643-25649. (Pubitemid 23358175)
34. Minghetti L, Nicolini A, Polazzi E et al. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia 1997;19:152-160. (Pubitemid 27094132)
35. Fournier T, Fadok V, Henson PM. Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase- 2 expression and prostaglandin E2 synthesis. J Biol Chem 1997;272:31065-31072. (Pubitemid 27527554)
36. Hinz B, Brune K, Pahl A. Prostaglandin E(2) upregulates cyclooxygenase- 2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun 2000;272:744-748. (Pubitemid 30420710)
37. Ludin A, Itkin T, Gur-Cohen S et al. Monocytes-macrophages that express alpha-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow. Nat Immunol 2012;13:1072-1082.
38. Shojaei F, Trowbridge J, Gallacher L et al. Hierarchical and ontogenic positions serve to define the molecular basis of human hematopoietic stem cell behavior. Dev Cell 2005;8:651-663. (Pubitemid 40585289)
39. Wilson A, Oser GM, Jaworski M et al. Dormant and self-renewing hematopoietic stem cells and their niches. Ann N Y Acad Sci 2007; 1106:64-75. (Pubitemid 47443057)
40. Simonnet AJ, Nehme J, Vaigot P et al. Phenotypic and functional changes induced in hematopoietic stem/progenitor cells after gammaray radiation exposure. Stem Cells 2009;27:1400-1409.
41. Mohrin M, Bourke E, Alexander D et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 2010;7:174-185.
42. Milyavsky M, Gan OI, Trottier M et al. A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell 2010;7:186-197.
43. Hanson WR. Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents. Radiat Res 1987;111:361-373. (Pubitemid 17156958)
44. Maisin JR, Albert C, Henry A. Reduction of short-term radiation lethality by biological response modifiers given alone or in association with other chemical protectors. Radiat Res 1993;135:332-337. (Pubitemid 23306518)
45. Berk LB, Patrene KD, Boggs SS. 16,16-Dimethyl prostaglandin E2 and/or syngeneic bone marrow transplantation increase mouse survival after supra-lethal total body irradiation. Int J Radiat Oncol Biol Phys 1990;18:1387-1392. (Pubitemid 20234150)
46. Lee SK, Lorenzo JA. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation. Endocrinology 1999;140:3552-3561. (Pubitemid 30645409)
47. Winkler IG, Sims NA, Pettit AR et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010;116:4815-4828.
48. Christopher MJ, Rao M, Liu F et al. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J Exp Med 2011;208:251-260.
49. Chow A, Lucas D, Hidalgo A et al. Bone marrow CD169 macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 2011;208: 261-271.
50. Stahl CP, Winton EF, Monroe MC et al. Recombinant human granulocyte- macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates. Exp Hematol 1991;19:810-816.